NMTR Annual CFO
-$37.24 M
-$7.76 M-26.34%
31 December 2022
Summary:
As of January 30, 2025, NMTR annual cash flow from operations is -$37.24 million, with the most recent change of -$7.76 million (-26.34%) on December 31, 2022. During the last 3 years, it has fallen by -$19.28 million (-107.28%).NMTR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMTR Quarterly CFO
-$9.75 M
-$11.10 K-0.11%
31 March 2023
Summary:
As of January 30, 2025, NMTR quarterly cash flow from operations is -$9.75 million, with the most recent change of -$11.10 thousand (-0.11%) on March 31, 2023. Over the past year, it has dropped by -$1400.00 (-0.01%).NMTR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMTR TTM CFO
-$37.24 M
-$1400.000.00%
31 March 2023
Summary:
As of January 30, 2025, NMTR TTM cash flow from operations is -$37.24 million, with the most recent change of -$1400.00 (0.00%) on March 31, 2023. Over the past year, it has dropped by -$4.24 million (-12.86%).NMTR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMTR Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.3% | -0.0% | -12.9% |
| 3 y3 years | -107.3% | -270.4% | -127.6% |
| 5 y5 years | -630.8% | -39.9% | -107.3% |
NMTR Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +2052.8% | -400.5% | -1248.1% |
9 Meters Biopharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$9.75 M(+0.1%) | -$37.24 M(+0.0%) |
| Dec 2022 | -$37.24 M(+26.3%) | -$9.74 M(-2.3%) | -$37.24 M(+5.0%) |
| Sept 2022 | - | -$9.97 M(+28.0%) | -$35.48 M(+5.3%) |
| June 2022 | - | -$7.79 M(-20.1%) | -$33.68 M(+2.1%) |
| Mar 2022 | - | -$9.75 M(+22.3%) | -$33.00 M(+12.0%) |
| Dec 2021 | -$29.48 M(+51.9%) | -$7.97 M(-2.5%) | -$29.48 M(+5.6%) |
| Sept 2021 | - | -$8.17 M(+15.0%) | -$27.93 M(+16.8%) |
| June 2021 | - | -$7.11 M(+14.2%) | -$23.91 M(+4.0%) |
| Mar 2021 | - | -$6.22 M(-3.0%) | -$23.00 M(+18.5%) |
| Dec 2020 | -$19.41 M(+8.0%) | -$6.42 M(+54.2%) | -$19.41 M(+19.7%) |
| Sept 2020 | - | -$4.16 M(-32.9%) | -$16.21 M(+1.1%) |
| June 2020 | - | -$6.20 M(+135.4%) | -$16.04 M(-2.0%) |
| Mar 2020 | - | -$2.63 M(-18.3%) | -$16.36 M(-8.9%) |
| Dec 2019 | -$17.97 M(+18.4%) | -$3.22 M(-19.2%) | -$17.97 M(+4.8%) |
| Sept 2019 | - | -$3.99 M(-38.8%) | -$17.15 M(+3.1%) |
| June 2019 | - | -$6.52 M(+53.8%) | -$16.64 M(+33.8%) |
| Mar 2019 | - | -$4.24 M(+75.9%) | -$12.44 M(-18.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$15.17 M(+197.6%) | -$2.41 M(-30.8%) | -$15.17 M(+3.3%) |
| Sept 2018 | - | -$3.48 M(+50.4%) | -$14.69 M(+19.2%) |
| June 2018 | - | -$2.31 M(-66.8%) | -$12.32 M(+9.6%) |
| Mar 2018 | - | -$6.97 M(+260.8%) | -$11.24 M(+120.6%) |
| Dec 2017 | -$5.10 M(-39.5%) | -$1.93 M(+73.8%) | -$5.10 M(-4.8%) |
| Sept 2017 | - | -$1.11 M(-9.8%) | -$5.36 M(-35.7%) |
| June 2017 | - | -$1.23 M(+50.0%) | -$8.33 M(-2.0%) |
| Mar 2017 | - | -$821.70 K(-62.5%) | -$8.50 M(+0.9%) |
| Dec 2016 | -$8.43 M(+387.1%) | -$2.19 M(-46.4%) | -$8.43 M(+6.3%) |
| Sept 2016 | - | -$4.08 M(+190.7%) | -$7.92 M(+112.9%) |
| June 2016 | - | -$1.41 M(+88.1%) | -$3.72 M(-34.9%) |
| Mar 2016 | - | -$747.00 K(-55.7%) | -$5.72 M(+230.7%) |
| Dec 2015 | -$1.73 M(-76.8%) | -$1.69 M(-1530.5%) | -$1.73 M(+4019.0%) |
| Sept 2015 | - | $118.00 K(-103.5%) | -$42.00 K(-73.8%) |
| June 2015 | - | -$3.40 M(-204.9%) | -$160.00 K(-104.9%) |
| Mar 2015 | - | $3.24 M | $3.24 M |
| Dec 2014 | -$7.45 M(+92.5%) | - | - |
| Dec 2013 | -$3.87 M | - | - |
FAQ
- What is 9 Meters Biopharma annual cash flow from operations?
- What is the all time high annual CFO for 9 Meters Biopharma?
- What is 9 Meters Biopharma annual CFO year-on-year change?
- What is 9 Meters Biopharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for 9 Meters Biopharma?
- What is 9 Meters Biopharma quarterly CFO year-on-year change?
- What is 9 Meters Biopharma TTM cash flow from operations?
- What is the all time high TTM CFO for 9 Meters Biopharma?
- What is 9 Meters Biopharma TTM CFO year-on-year change?
What is 9 Meters Biopharma annual cash flow from operations?
The current annual CFO of NMTR is -$37.24 M
What is the all time high annual CFO for 9 Meters Biopharma?
9 Meters Biopharma all-time high annual cash flow from operations is -$1.73 M
What is 9 Meters Biopharma annual CFO year-on-year change?
Over the past year, NMTR annual cash flow from operations has changed by -$7.76 M (-26.34%)
What is 9 Meters Biopharma quarterly cash flow from operations?
The current quarterly CFO of NMTR is -$9.75 M
What is the all time high quarterly CFO for 9 Meters Biopharma?
9 Meters Biopharma all-time high quarterly cash flow from operations is $3.24 M
What is 9 Meters Biopharma quarterly CFO year-on-year change?
Over the past year, NMTR quarterly cash flow from operations has changed by -$1400.00 (-0.01%)
What is 9 Meters Biopharma TTM cash flow from operations?
The current TTM CFO of NMTR is -$37.24 M
What is the all time high TTM CFO for 9 Meters Biopharma?
9 Meters Biopharma all-time high TTM cash flow from operations is $3.24 M
What is 9 Meters Biopharma TTM CFO year-on-year change?
Over the past year, NMTR TTM cash flow from operations has changed by -$4.24 M (-12.86%)